Artelo Biosciences Inc. (ARTLW)
Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results
Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results
Protara Therapeutics to Participate in Upcoming Investor Conferences
Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference
Mallinckrodt and Endo Announce Significant Progress in Proposed Merger
CareCloud Named “Top Healthcare IT Pick for 2025” by Maxim Group; AI Initiative Recognized as Key Growth Driver
iTeos Reports Topline Interim Results from GALAXIES Lung-201 Study of Belrestotug + Dostarlimab in First-Line, PD-L1 High Non-Small Cell Lung Cancer Patients
Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update
MediWound
First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study
Adaptimmune Reports Q1 Financial Results and Provides Business Update